Home News New rapid testing device for COVID-19 immunity
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

New rapid testing device for COVID-19 immunity

by wrich

Exeter-based companies develop test to tell you if you have had COVID-19 and if your vaccine worked

Electronics specialist Mantracourt has helped engineer a new rapid test which will tell people whether they have immunity against coronavirus and whether that immunity comes from developing antibodies after infection or the vaccine. The device, which is a UK first, was designed by Attomarker, a spin-out company from the University of Exeter, and is currently in use at their Exeter-based clinic. 

Attomarker, a spin-out company from the University of Exeter, has developed a new COVID-19 triple antibody testing device to tell people whether they have antibodies protecting them against COVID-19 and whether those antibodies come from vaccination or a previous infection. The rapid testing machine was developed in collaboration with Exeter-based company Mantracourt who have taken the initial design through to production, standardisation and testing.

“We started off by building the device for Attomarker, but it quickly became apparent that there were other areas where we could assist to deliver the project such as machine validation testing,” explained Robert Badcock, managing director at Mantracourt. “We undertook pre-compliance testing and discovered the electronics and communication systems in the device could be improved.

“We designed a new power distribution module, new USB components and a USB hub, as well as replacing several of the specified cables in the unit,” added Badcock. “Overall, we managed to improve the kit while reducing around 60 per cent of the cost and also reduced noise, which is important from an EMC point of view.”

Mantracourt’s agile manufacturing capabilities meant that the company was able to take Attomarker’s design and specifications and refine it thanks to its expertise in electronics and mass-production requirements. 

“We took the design concept and helped Attomarker make it more suitable for mass production”, continued Badcock. “Mantracourt is very used to helping our customers find efficiencies and opportunities during the design cycle which means we can quickly start manufacturing. Ultimately, our involvement in this project helped finalise the device and bring it to market much sooner”. 

Attomarker’s seven-minute COVID-19 antibody testing device has been launched in Exeter-based clinics and is due to be rolled out across the UK as a national service to those aged 16 and over.

To find out more about Mantracourt’s mechanical design expertise and how the team can help manage your mechanical production processes, visit www.mantracourt.com give us a call on +44 (0) 1395 232 400.

You may also like